Literature DB >> 18632819

Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation.

Kooresh I Shoghi1, Robert J Gropler, Terry Sharp, Pilar Herrero, Nicole Fettig, Yi Su, Mayurranjan S Mitra, Attila Kovacs, Brian N Finck, Michael J Welch.   

Abstract

UNLABELLED: Diabetic cardiomyopathy is associated with abnormalities in glucose metabolism. We evaluated myocardial glucose metabolism in a rodent model of type 2 diabetes, namely the Zucker diabetic fatty (ZDF) rat, and validated PET measurements of glucose uptake against gene and protein expression of glucose transporters (GLUTs).
METHODS: Six lean and ZDF rats underwent small-animal PET at the age of 14 wk and at the age of 19 wk. The imaging protocol consisted of a 60-min dynamic acquisition with 18F-FDG (18.5-29.6 MBq). Dynamic images were reconstructed using filtered backprojection with a 2.5 zoom on the heart and 40 frames per imaging session. PET measurements of myocardial glucose uptake (MGUp) rate and utilization were determined with an input function derived by the hybrid image-blood-sampling algorithm on recovery-corrected anterolateral myocardial regions of interest. After the PET session at week 19 (W19), hearts were extracted for gene and protein expression analysis of GLUT-1 and GLUT-4. The dependence of MGUp on gene expression of GLUT-1 and GLUT-4 was characterized by multiple-regression analysis.
RESULTS: MGUp in ZDF rats at both week 14 (W14) and W19 (P < 0.006) was significantly lower than MGUp in lean littermate control rats. Moreover, lean rats at W19 displayed significantly higher MGUp than they did at W14 (P = 0.007). Consistent with a diminished MGUp result, gene expression of GLUT-4 was significantly (P = 0.004) lower in ZDF rats. Finally, MGUp significantly (P = 0.0003) correlated with gene expression of GLUT-4.
CONCLUSION: Using small-animal PET, we confirmed alterations in myocardial glucose utilization and validated PET measurement of MGUp against gene and protein expression of GLUTs in the diabetic heart of an animal model of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632819      PMCID: PMC2857655          DOI: 10.2967/jnumed.108.051672

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.

Authors:  Pilar Herrero; Terry L Sharp; Carmen Dence; Brendan M Haraden; Robert J Gropler
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

2.  [1-14C]-2-deoxy-d-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants.

Authors:  L Sokoloff
Journal:  Neurosci Res Program Bull       Date:  1976-09

3.  Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose.

Authors:  M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; B Gallagher; E Hoffman; A Alavi; L Sokoloff
Journal:  Acta Neurol Scand Suppl       Date:  1977

Review 4.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

Review 6.  Metabolic abnormalities in the diabetic heart.

Authors:  Gary D Lopaschuk
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 7.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Zhi You Fang; Johannes B Prins; Thomas H Marwick
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

8.  Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.

Authors:  M Saddik; G D Lopaschuk
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

9.  Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease.

Authors:  A Avogaro; R Nosadini; A Doria; P Fioretto; M Velussi; C Vigorito; L Saccà; G Toffolo; C Cobelli; R Trevisan
Journal:  Am J Physiol       Date:  1990-04

10.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

View more
  31 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

Review 3.  Imaging diabetes mellitus with coronary computed tomography angiography, cardiovascular magnetic resonance, and positron emission tomography.

Authors:  Maleah Grover-McKay
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

Review 4.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 5.  Recent advances in metabolic imaging.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

6.  Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Authors:  Albert Wu; Huaiyu Zheng; Jennifer Kraenzle; Ashley Biller; Carol D Vanover; Mary Proctor; Leslie Sherwood; Marlene Steffen; Chin Ng; Daniel J Mollura; Colleen B Jonsson
Journal:  ILAR J       Date:  2012

7.  Transcript levels of class I GLUTs within individual tissues and the direct relationship between GLUT1 expression and glucose metabolism in Atlantic cod (Gadus morhua).

Authors:  Jennifer R Hall; Kathy A Clow; Connie E Short; William R Driedzic
Journal:  J Comp Physiol B       Date:  2014-02-20       Impact factor: 2.200

8.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

9.  Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo.

Authors:  Min Zhong; Clayton E Alonso; Heinrich Taegtmeyer; Bijoy K Kundu
Journal:  J Nucl Med       Date:  2013-02-20       Impact factor: 10.057

10.  Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.

Authors:  Charissa E van den Brom; Marc C Huisman; Ronald Vlasblom; Nicky M Boontje; Suzanne Duijst; Mark Lubberink; Carla F M Molthoff; Adriaan A Lammertsma; Jolanda van der Velden; Christa Boer; D Margriet Ouwens; Michaela Diamant
Journal:  Cardiovasc Diabetol       Date:  2009-07-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.